trial · primary record
SC-101
Advanced Solid Tumor
| Phase | Phase 1 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 100 |
| Primary completion | 2027-09-30 |
| Primary endpoint | Incidence of adverse events (dose escalation phase) |
| Registry ID | NCT06220838 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-28T13:42:52.783Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT06220838
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.